Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARO-DECAMP: MET-2 for ARO Decolonization
NCT06214403Phase 2Withdrawn
- Sponsor
- University Health Network
- Start
- Jul 2026
- Primary completion
- Jan 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of MET-2 in Infection, gram-negative bacteremia, sponsored by University Health Network. Planned start Jul 2026; status: withdrawn.
02
Drugs
MET-2
03
Conditions
Infectiongram-negative bacteremia
Beyond the preview
Go deeper on NCT06214403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06214403.